Ibutilide
Corvert, Ibutilide (ibutilide) is a small molecule pharmaceutical. Ibutilide was first approved as Corvert on 1995-12-28. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. The pharmaceutical is active against voltage-gated inwardly rectifying potassium channel KCNH2; potassium voltage-gated channel subfamily H member 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| cardiovascular diseases | D002318 |
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Corvert, Ibutilide (discontinued: Ibutilide)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| corvert | New Drug Application | 2024-01-25 |
| ibutilide fumarate | ANDA | 2025-11-04 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| atrial fibrillation | EFO_0000275 | D001281 | I48.0 |
| atrial flutter | EFO_0003911 | D001282 | — |
| cardiac arrhythmias | EFO_0004269 | D001145 | I49.9 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J1742 | Injection, ibutilide fumarate, 1 mg |
Clinical
Clinical Trials
9 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | 1 | 4 | 5 |
| Long qt syndrome | D008133 | HP_0001657 | I45.81 | — | 1 | — | 3 | — | 4 |
| Torsades de pointes | D016171 | EFO_0005307 | I47.21 | — | 1 | — | 1 | — | 2 |
| Drug-induced abnormalities | D000014 | — | — | — | — | — | 2 | — | 2 |
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Jervell-lange nielsen syndrome | D029593 | Orphanet_90647 | I45.8 | — | 1 | — | — | — | 1 |
| Sudden death | D003645 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Ibutilide |
| INN | ibutilide |
| Description | Ibutilide is an organic amino compound and a member of benzenes. |
| Classification | Small molecule |
| Drug class | class III antiarrhythmic agents |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 122647-31-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL533 |
| ChEBI ID | 5856 |
| PubChem CID | 60753 |
| DrugBank | DB00308 |
| UNII ID | 2436VX1U9B (ChemIDplus, GSRS) |
Target
Agency Approved
KCNH2
KCNH2
Organism
Homo sapiens
Gene name
KCNH2
Gene synonyms
ERG, ERG1, HERG
NCBI Gene ID
Protein name
potassium voltage-gated channel subfamily H member 2
Protein synonyms
Eag homolog, Eag-related protein 1, ERG-1, Ether-a-go-go-related gene potassium channel 1, ether-a-go-go-related potassium channel protein, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1, human ether-a-go-go-related, long QT syndrome type 2, potassium channel, voltage gated eag related subfamily H, member 2, potassium voltage-gated channel, subfamily H (eag-related), member 2, Voltage-gated potassium channel subunit Kv11.1
Uniprot ID
Mouse ortholog
Kcnh2 (16511)
potassium voltage-gated channel subfamily H member 2 (O35989)
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,069 documents
View more details
Safety
Black-box Warning
Black-box warning for: Corvert
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
34 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use